View all / combine content
14-5, Consolidation and Disclosure Considerations Related to Venezuelan Operations14-4, Financial Reporting Considerations Related to Pension and Other Postretirement Benefits14-3, Segment Reporting14-2, Accounting for the Branded Pharmaceutical Drug Annual Fee — Effect of the Final IRS Regulations Issued in July 201414-1, Foreign Currency Exchange Accounting Implications of Recent Government Actions in Venezuela
14-5, Consolidation and Disclosure Considerations Related to Venezuelan Operations14-4, Financial Reporting Considerations Related to Pension and Other Postretirement Benefits14-3, Segment Reporting14-2, Accounting for the Branded Pharmaceutical Drug Annual Fee — Effect of the Final IRS Regulations Issued in July 201414-1, Foreign Currency Exchange Accounting Implications of Recent Government Actions in Venezuela